Back to Results
First PageMeta Content
Biology / Ovarian hyperstimulation / Gonadotropin-releasing hormone agonist / In vitro fertilisation / Transvaginal oocyte retrieval / Gonadotropin-releasing hormone antagonist / Polycystic ovary syndrome / Human chorionic gonadotropin / Gonadotropin-releasing hormone / Medicine / Fertility medicine / Human reproduction


SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the
Add to Reading List

Document Date: 2014-11-11 15:42:13

Open Document

File Size: 127,08 KB

Share Result on Facebook

City

Toronto / London / Ottawa / /

Company

C. / Medline / Sony / /

Event

Natural Disaster / /

Facility

Cochrane Library / /

IndustryTerm

antagonist protocol / research / antagonist stimulation protocols / health technology assessment / Prevention of Ovarian Hyperstimulation Syndrome / antagonist protocols / /

MedicalCondition

severe ovarian hyperstimulation syndrome / ovarian hyperstimulation syndrome / disease / polycystic ovarian syndrome / severe prolonged ovarian hyperstimulation syndrome / /

MedicalTreatment

embryo transfer / ovarian stimulation / in vitro fertilization / /

Organization

Reproductive Endocrinology Infertility Committee / Society of Obstetricians and Gynaecologists of Canada / Canadian Task Force on Preventive Health Care / Canadian Task Force on Preventive Health Care Quality / /

Person

Mathias Gysler / David Smithson / Ward Murdock / Robert Hemmings / Allison Case / Shannon Corbett / Jon Havelock / Kimberly Liu / Anthony Cheung / James Graham / Sierra / Cathie Dwyer / /

Position

Executive / Co-chair / /

Product

penicillin / chorionic gonadotropin / Cabergoline / /

ProvinceOrState

Maryland / /

Technology

antagonist protocol / GnRH antagonist protocols / antagonist stimulation protocols / /

SocialTag